Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 5/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | TERT | O14746 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 9/20 | 0.32 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31346109 | 1.00 | ELANE (0.34) | ELANECYP3A4EGLN1TERTKIF11 | |
| SCHEMBL31346114 | 0.92 | KIF11 (0.36) | ELANECYP3A4EGLN1KIF11MRGPRX4 | |
| SCHEMBL31346129 | 0.87 | TRPM5 (0.35) | ELANECYP3A4EGLN1KIF11MAOB | |
| SCHEMBL31345991 | 0.85 | ABCG2 (0.37) | CYP3A4MAOB | |
| SCHEMBL31346117 | 0.83 | CYP19A1 (0.45) | ELANECYP3A4KIF11MRGPRX4 | |
| SCHEMBL31345995 | 0.83 | CYP19A1 (0.45) | ELANECYP3A4KIF11MRGPRX4 | |
| SCHEMBL31346060 | 0.82 | TERT (0.34) | TERTMAOB | |
| SCHEMBL31346038 | 0.82 | TERT (0.34) | TERTMAOB | |
| SCHEMBL31346029 | 0.81 | CYP11B1 (0.40) | CYP3A4EGLN1KIF11 | |
| SCHEMBL31346086 | 0.80 | MRGPRX4 (0.34) | ELANEEGLN1KIF11MRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |